Identification of Some α-Glucosidase Inhibitors Using QSAR Modeling Based Drug Repurposing Approach

Authors

Abstract

Post-prandial hyperglycemia still remains a problem in the management of type II diabetes mellitus. Of all available anti-diabetic drugs, α-glucosidase inhibitors seem to be one of the most effective in reducing post-prandial hyperglycemia. In present study, QSAR modeling based drug repurposing approach has been implemented to identify some repurposed α-glucosidase inhibitors with established safety profile. For this QSAR modeling based analysis, initially a series of N’-Benzylidenebenzoylhydrazide having two different types of substitutions on Benzylidene and Benzoyl part as well as proper variation in the biological activity was selected thereafter models were developed using various conventional QSAR approaches including Free Wilson, Hansch, and Mixed modeling by utilizing PaDEL descriptor calculator and DTC lab software. Hansch type 2D QSAR model, which was derived using some PaDEL descriptor, showed acceptable internal as well as external consistencies. Some repurposed α-glucosidase inhibitors were successfully identified. These identified approved drugs may be further explored as new anti-diabetics for type II diabetes patient especially for the management of post-prandial hyperglycemia which is a major issue in these patients.

Keywords:  QSAR, Hyperglycemia, Substitutions, Diabetes mellitus, PaDEL descriptor

Keywords:

QSAR, Hyperglycemia, Substitutions, Diabetes mellitus, PaDEL descriptor

DOI

https://doi.org/10.22270/jddt.v15i3.7029

Author Biographies

Sonu , Ph. D. Research scholar RKDF University Bhopal (M.P.), India

Ph. D. Research scholar RKDF University Bhopal (M.P.), India

Mohan Lal Kori , Vice Chancellor, Tantya Bhil University Khargone (M.P.), India

Vice Chancellor, Tantya Bhil University Khargone (M.P.), India

References

1. Pizzi RA. Defying diabetes: The discovery of insulin. Modern Drug Discovery 2000; 3(6):77-80.

2. APh A Special Report. New approaches to insulin therapy for diabetes. American Pharmaceutical Association, Washington DC 2001.

3. Derosa G, Maffioli P. α-Glucosidase inhibitors and their use in clinical practice, Arch Med Sci 2012; 5:899-906 https://doi.org/10.5114/aoms.2012.31621 PMid:23185202 PMCid:PMC3506243

4. Wehmeier U, Piepersberg W. Biotechnology and molecular biology of the α - glucosidase inhibitor acarbose, Appl. Microbiol. Biot. 2004; 63:613-625. https://doi.org/10.1007/s00253-003-1477-2 PMid:14669056

5. Narita T, Yokoyama H, Yamashita R, Sato T, Hosoba M, Morii T., et al., Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients, Diabetes. Obes. Metab. 2011; 14:283-287. https://doi.org/10.1111/j.1463-1326.2011.01526.x PMid:22051162

6. Derosa G, Mereu R, D'Angelo A, Salvadeo S, Ferrari I, Fogari E, et al., Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin, J. Clin. Pharm. Ther. 2010; 35:565-579. https://doi.org/10.1111/j.1365-2710.2009.01132.x PMid:20831680

7. Derosa G, Maffioli P. Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practice, Arch. Med. Sci. 2012; 5:899-906. https://doi.org/10.5114/aoms.2012.31621 PMid:23185202 PMCid:PMC3506243

8. Holt R, Lambert K. The use of oral hypoglycaemic agents in pregnancy, Diabet. Med. 2014; 31:282-291. https://doi.org/10.1111/dme.12376 PMid:24528229

9. Syahrul I. et al. Synthesis of novel flavone hydrazones: In-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies Eur. J. Med. Chem., 2015; 105:156-170. https://doi.org/10.1016/j.ejmech.2015.10.017 PMid:26491979

10. Muhammad T. et al. Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies, Eur. J. Med. Chem, 2015; 92:387-400. https://doi.org/10.1016/j.ejmech.2015.01.009 PMid:25585009

11. Farman A, et al. Hydrazinyl arylthiazole based pyridine scaffolds: Synthesis, structural characterization, in vitro α-glucosidase inhibitory activity, and in silico studies, Eur. J. Med. Chem., 2017; 138:255-272. https://doi.org/10.1016/j.ejmech.2017.06.041 PMid:28672278

12. Flynn GL. Substituent constants for correlation analysis in chemistry and biology. By Corwin Hansch and Albert Leo. Wiley, 605 Third Ave., New York, NY 10016. 1979.

13. Golbraikh A, Tropsha A., Beware of Q2, J Mol Graph Model, 2002; 20:269-76. https://doi.org/10.1016/S1093-3263(01)00123-1 PMid:11858635

14. Krzywinski M, Altman N. Classification and regression trees. Nat Methods. 2017; 14(8):757. doi: 10.1038/nmeth.4370. https://doi.org/10.1038/nmeth.4370

15. Costa VG, Pedreira CE. Recent advances in decision trees: an updated survey. Artif Intell Rev. 2023; 56:4765-4800. https://doi.org/10.1007/s10462-022-10275-5

16. Ahn S, Lee SE, Kim M. Random-forest model for drug-target interaction prediction via Kullback-Leibler divergence. J Chemin- 2022; 14:67. https://doi.org/10.1186/s13321-022-00644-1 PMid:36192818 PMCid:PMC9531514

17. Kapsiani S, Howlin BJ. Random forest classification for predicting lifespan-extending chemical compounds. Sci Rep. 2021;11 https://doi.org/10.1038/s41598-021-93070-6 PMid:34226569 PMCid:PMC8257600

18. Yu F, Wei C, Deng P, Peng T, Hu X. Deep exploration of random forest model boosts the interpretability of machine learning studies of complicated immune responses and lung burden of nanoparticles. Sci Adv. 2021; 7 https://doi.org/10.1126/sciadv.abf4130 PMid:34039604 PMCid:PMC8153727

19. Tharwat A. Parameter investigation of support vector machine classifier with kernel functions. Knowl Inf Syst. 2019; 61:1269-1302. https://doi.org/10.1007/s10115-019-01335-4

Published

2025-03-15
Statistics
Abstract Display: 216
PDF Downloads: 383
PDF Downloads: 28

How to Cite

1.
Sonu D, Kori ML. Identification of Some α-Glucosidase Inhibitors Using QSAR Modeling Based Drug Repurposing Approach. J. Drug Delivery Ther. [Internet]. 2025 Mar. 15 [cited 2026 Jan. 20];15(3):36-52. Available from: https://jddtonline.info/index.php/jddt/article/view/7029

How to Cite

1.
Sonu D, Kori ML. Identification of Some α-Glucosidase Inhibitors Using QSAR Modeling Based Drug Repurposing Approach. J. Drug Delivery Ther. [Internet]. 2025 Mar. 15 [cited 2026 Jan. 20];15(3):36-52. Available from: https://jddtonline.info/index.php/jddt/article/view/7029

Most read articles by the same author(s)